Close

MediWound (MDWD) Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns Mets Primary Endpoints

Go back to MediWound (MDWD) Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns Mets Primary Endpoints

MediWound (MDWD) to Resume Trading at 7:30 a.m.

July 20, 2021 7:10 AM EDT

MediWound (NASDAQ: MDWD) to Resume Trading at 7:30 a.m.

... More